"UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital - New Lenox offers advanced, personalized cancer care that's closer to home. Our world-class oncology team provides state-of-the-art treatment for adults in a convenient Will County setting. Our services include radiation therapy, on-site chemotherapy and infusion treatments, pre- and post-transplant care for stem cell transplantation, as well as cancer screenings and supportive care services such as patient support groups. And our robust clinical trial program gives patients access to novel medications and treatments before they're widely available."

During the past decade, UC Comprehensive Cancer Center at Silver Cross conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 45 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 41 clinical trials were completed. i.e. 91.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC Comprehensive Cancer Center at Silver Cross" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "NRG Oncology" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC Comprehensive Cancer Center at Silver Cross" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "UC Comprehensive Cancer Center at Silver Cross" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Recurrent Fallopian Tube Carcinoma" (6 trials). Many other conditions were trialed in "UC Comprehensive Cancer Center at Silver Cross" in a lesser frequency.

Most popular intervention types in "UC Comprehensive Cancer Center at Silver Cross" are "Drug" (109 trials), "Other" (79 trials), "Biological" (57 trials), "Procedure" (43 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (34 trials), "Computed Tomography" (24 trials), "Biospecimen Collection" (23 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "UC Comprehensive Cancer Center at Silver Cross" are 102 trials for "All" genders, 31 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UC Comprehensive Cancer Center at Silver Cross". undefined are not yet recruiting, 37 are recruiting, 68 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in UC Comprehensive Cancer Center at Silver Cross, 6 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UC Comprehensive Cancer Center at Silver Cross, 10 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".